Pharma Consulting Plays A Fundamental Role In Maximising Pharmaceutical Gains

Our healthcare system is extremely complicated, with a lot of moving parts, but is nevertheless one of our most important economic drivers. There are many different incentives and restrictions governing the use of an individual pharmaceutical product and many different agendas along the way. Before a solution to the patient's problem may be presented, it has to face a complex path from the scientist at one end to the sufferer at the other. Invariably, pharmaceutical consultants are critical to this journey, as they help all those involved to understand the situation, disseminate the information and make decisions.

A pharmaceutical company faces many challenges, quite apart from the manufacture of its products. As a pharmaceutical consulting firm stresses, the company owes the consumer in general a debt of revelation. Most often, the pharmaceutical companies are at the cutting-edge of science and help to uncover solutions or possibilities previously unheard-of. Without an adequate marketing channel, these findings might never make their way via the regulators to the front-line professionals. Those with a financial interest, especially the all important insurers, will also benefit from a good marketing approach, as they will be made aware of the positive features and benefits associated.

Before a new product may arrive on the desk of the regulators, who determine its future, the company must have marketed both its products and its history within a very competitive and busy environment. It should be noted that certain principals within the industry have an incentive to steer healthcare practitioners and their patients toward older, or generic medications and that these agendas may not be in the best interests of the sufferer. Pharmaceutical companies have a clear incentive to trumpet the benefits of their wares in such a noisy marketplace and help to create a dynamic and forward thinking mindset.

It is unfortunate that the ultimate care of the patient is very often not the ultimate goal of certain vested interests. In popular opinion, healthcare reform is always controversial and the pharmaceutical company would do well to accurately and forcefully communicate its position. The harried physician must listen to many different interested parties before a decision can be made about the patient, including the views of other professionals, training and education, patient restrictions, formularies, best practices and traditions. If you consider that nine out of ten most frequently prescribed drugs are generics, it should be clear that far from being in a position of dominance, pharmaceutical companies must make every effort to ensure that their marketing messages are heard. In most cases, pharma consulting firms are used to this difficult environment and can certainly help to open channels and engage practices.

Pharmaceutical companies have been responsible for many of the most amazing discoveries in the world of medicine. Cures that would have been unheard-of a generation ago are now commonplace. To enable healthcare to continue to get better, much emphasis must be placed on marketing.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.